Palliative care physicians' perspectives of management for terminally ill cancer patients with death rattle: a nationwide survey.

Palliative care physicians' perspectives of management for terminally ill cancer patients with death rattle: a nationwide survey.
复制标题

姑息治疗医生对临终癌症患者临终声音管理的看法:一项全国性调查。

DOI:
10.1093/jjco/hyaa044
复制
发表时间:
2020
期刊:
Jpn J Clin Oncol.
影响因子:
--
通讯作者:
Yamaguchi T.
Yamaguchi T.
中科院分区:
--
文献类型:
--
作者:
Matsunuma R;Suzuki K;Matsuda Y;Mori M;Watanabe H;Yamaguchi T.

文献摘要

参考文献

被引文献

相似文献

临终前的最后几天会出现这种病,患者的亲属经常报告说,这种病非常痛苦。本研究旨在探讨日本姑息治疗医师在日本临床实务中的认知。我们通过匿名的自我报告问卷对268名医生进行了一项全国性调查。我们评估了药物和非药物管理和抗胆碱能药物的选择。189名医生(70.5%)返回了调查问卷。55名(29.1%)治疗1型(真实的死亡拨浪鼓)患者的参与者和36名(19%)治疗2型(假性死亡拨浪鼓)死亡拨浪鼓患者的参与者报告称,他们经常使用抗胆碱能药物。四分之一的人服用丁溴东莨菪碱或氢溴酸东莨菪碱。总之,更多的日本姑息治疗医生认为,抗胆碱能药物可能是有效的治疗1型而不是2型死亡摇铃。需要对这些药物进行进一步的临床试验。
Death rattle occurs during the last days of life, and relatives of those afflicted frequently report that it is very distressful. However, there is no effective treatment for it. The purpose of this study was to investigate the perceptions of Japanese palliative care physicians in clinical practice in Japan. We conducted a nationwide survey of 268 physicians via an anonymous, self-report questionnaire. We assessed pharmacological and non-pharmacological management and anticholinergic agent choice. One hundred eighty-nine physicians (70.5%) returned the questionnaires. Fifty-five participants (29.1%) treating patients with Type-1 (real death rattle) and 36 participants (19%) treating patients with Type-2 (pseudo-death rattle) death rattle reported that they would frequently administer an anticholinergic agent. One-fourth would administer scopolamine butylbromide or scopolamine hydrobromide. In conclusion, more Japanese palliative care physicians thought that anticholinergic agents might be effective for treating Type-1 death rattle rather than Type-2. Further clinical trials of these agents are needed.
DOI: 10.1016/j.jpainsymman.2012.01.006
发表时间: 2013-01-01
影响因子: 4.7
作者:
Heisler, Mark;Hamilton, Gillian;Gerkin, Richard
通讯作者: Gerkin, Richard
临终遗言:东莨菪碱(东莨菪碱)使用审核和管理审查。
DOI: --
发表时间: 1996
影响因子: 4.7
作者:
Michael I. Bennett
通讯作者: Michael I. Bennett
DOI: 10.1016/j.jpainsymman.2018.08.018
发表时间: 2018-12-01
影响因子: 4.7
作者:
Mercadante, Sebastiano;Marinangeli, Franco;Aielli, Federica
通讯作者: Aielli, Federica
临终遗言:对姑息治疗工作人员和志愿者的影响
DOI: 10.1177/0269216307087146
发表时间: 2008
影响因子: 4.4
作者:
B. Wee;P. Coleman;R. Hillier;S. Holgate
通讯作者: S. Holgate
临终时的嘎嘎声一:亲人听到这个声音是否心疼?
DOI: 10.1191/0269216306pm1137oa
发表时间: 2006
影响因子: 4.4
作者:
B. Wee;PG Coleman;R. Hillier;S. Holgate
通讯作者: S. Holgate